Exo Imaging is a company pioneering a high-performance ultrasound platform based on patented Piezoelectric Micromachined Ultrasonic Transducers (pMUT) technology and artificial intelligence (AI) for imaging and therapeutic applications.
Exo (pronounced “Echo”) is bringing diagnostic-grade medical imaging to the pocket of every caregiver and clinician worldwide.
Exo Imaging was founded in 2015 by Sandeep Akkaraju, Janusz Bryzek, Yusuf Haque and John Kokulis. The company is headquartered in Redwood City, California.
Exo’s pioneering ultrasound platform enables high performance imaging, while breaking down the barriers of cost and accessibility that have historically handicapped the broader utilization of medical imaging.
Exo is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high quality medical imaging, Exo will empower healthcare professionals to make critical, real-time decisions that improve patient outcomes.
The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging.
Exo Imaging is backed by Intel Capital, Applied Ventures, Fiscus Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Reimagined Ventures, Magnetar Capital, DK Ventures and others. The company raised an additional $40M to its Series B round on Aug 20, 2020. The additional financing follows a $35M raised on Aug 05, 2020, brining the Series B total to $75M. This also brings the total raised by the company to $87.6M to date.